ABBV-142
Idiopathic Pulmonary Fibrosis
Clinical trials
1
Developer
AbbVie
Overview
ABBV-142 is an agent tracked by PF-Atlas in the context of idiopathic pulmonary fibrosis. It appears in 1 tracked IPF clinical trial.
ABBV-142 clinical trials
Explore related
Medical disclaimer. This page summarizes research about ABBV-142 for information only. It is not medical advice. Verify approval status and evidence with the FDA and a pulmonologist.